An interesting telemedicine story from Brazil told in Israel
Here's how providers at the Hospital Israelita Albert Einstein in Brazil take care of workers on an oil platform away from the continent.
Morning Read: Why the medical industry should pay more attention to the Zika virus
Also, The World Health Organization has posted a final version of its proposed biologics naming policy, and new research suggests that the financial burden that cancer care puts on many people contributes to lower survival rates.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
The FDA wants more medical device companies to get on board with the international audit program
Not many medical device companies are stepping up to participate in the international Medical Device Single Audit Program, which has the FDA peeved.
Infographic: Physicians becoming more proficient with EHRs
Physicians are not only becoming more proficient with EHRs, they are using their systems for more than just reference. That's the conclusion of a new Accenture survey of more than 2,600 doctors in Australia, Brazil, England, Norway, Singapore and the U.S.
Is Brazil an emergent health IT market yet?
Brazil in all accounts has been categorized as an emerging market. However, is its healthcare market ready for a sustainable information technology transformation yet? A 21st century goal of a sustainable healthcare IT infrastructure will require crucial IT infrastructural implementations before hospitals and all other stakeholders in a national wide scale can benefit from information […]
N.C. pharma Pozen inks licensing deal for migraine drug in Latin America
The migraine drug developed by pharmaceutical company Pozen now has the opportunity for commercialization in parts of Latin America under a new licensing deal inked with a Johnson & Johnson subsidiary. Chapel Hill, North Carolina-based Pozen (NASDAQ:POZN) has already commercialized its compound MT 400 under the name Treximet, which is marketed through partner GlaxoSmithKline (NYSE:GSK). […]
presented by
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.